Guardant Health (GH) FCF Margin (2017 - 2026)

Guardant Health has disclosed FCF Margin across 10 years of filings, most recently posting 20.76% for Q2 2026.

• In Q2 2026, FCF Margin rose 765.0% year-over-year to 20.76%; the TTM figure through Jun 2026 stood at 20.35% (up 1244.0% YoY), while the FY2025 annual figure was 23.73%, up 1347.0% from the prior year.
• FCF Margin came in at 20.76% for Q2 2026 at Guardant Health, up from 23.6% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 17.26% in Q3 2025 to a low of 123.66% in Q2 2022.
• Average FCF Margin over 5 years is 48.8%, with a median of 47.36% recorded in 2024.
• Year-over-year, FCF Margin tumbled 3542 bps in 2022 and surged 5072 bps in 2023.
• Over 5 years, FCF Margin stood at 79.4% in 2022, then soared by 33 bps to 53.4% in 2023, then grew by 23 bps to 41.32% in 2024, then surged by 53 bps to 19.28% in 2025, then slipped by 8 bps to 20.76% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 20.76% in Q2 2026, 23.6% in Q1 2026, and 19.28% in Q4 2025.